Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...
The Standard-Times on MSN
Walker named director of programs at SouthCoast Community Foundation
SouthCoast Community Foundation has named Samia Walker as its new director of programs, effective Jan. 5, 2026.
OTA agreement provides for construction and operation of Project TETRA, Terrestrial Energy’s pilot reactor using Integral ...
Nimbus Therapeutics announced it has entered into a multi-year research collaboration and $1.3 exclusive license agreement ...
Nuveen Green Capital and Lone Star PACE Facilitate $21.9 Million C-PACE Transaction for New Multifamily Development North of ...
Lee Fleisher oversaw the development of the ‘hospital at home’ CMS waiver. Congress must update the program, he writes.
Initial clinical data from the ongoing Phase 1 study of ACR-2316, a potential first- and best-in-class WEE1/PKMYT1 inhibitor, ...
The rise of the commercial space industry precipitated a steeper decline at Rocketdyne. Boeing sold the Rocketdyne division ...
A North Carolina-headquartered developer of small modular nuclear power plants announced it has an agreement with the U.S. Dept. of Energy (DOE) for an initiative to build and operate a molten salt ...
ARC Clean Technology has raised Series B funding to accelerate commercialisation of its 100 MWe sodium‑cooled fast reactor, ...
BUFFALO, N.Y. – Lafayette International High School (PS 207) students with an interest in architecture will soon be able to ...
Hill Helicopters engineered composite main rotor blades using a novel single-cure manufacturing process for stiffness and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback